Henrik Rasmussen

Henrik Rasmussen is an Associate Professor in the Department of Comparative Medicine at the University of Oslo. His research focuses on immunology, pharmacology, and microbial pathogenesis, with notable work on microbial influences during early life and drug safety evaluation. He has contributed to studies on bile duct inflammation, immune modulation, and the efficacy of drugs like buprenorphine in surgical settings.

Key research areas include the role of microbial exposure in immune development and the application of comparative models to evaluate drug safety. His work bridges basic science and translational medicine, often involving animal studies to assess clinical outcomes.

Publications highlight interdisciplinary approaches, including studies on Streptococcus pneumoniae protection via plant extracts and toxicological evaluations of synthetic vitamins and contrast media. No awards or grants are explicitly mentioned in the provided text.